Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Equillium, Inc. (EQ)

Atara Biotherapeutics, Inc. and Equillium, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Equillium, Inc. are of similar size ($92.6M and $91.3M). Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against −96.7%. Equillium, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Equillium, Inc. leads on 10 and Atara Biotherapeutics, Inc. on 4.

Valuation

Metric ATRA EQ Biotechnology median
P/E n/m n/m 8.68
P/S 22.91 3.89 10.29
P/B n/m 2.85 2.40
Price to free cash flow n/m n/m 20.52
EV/EBITDA n/m n/m 0.68
EV/Sales 21.32 2.68 10.15
Earnings yield (12.50%) (13.99%) (28.86%)
Free cash flow yield (14.82%) (12.56%) (22.44%)

Profitability

Metric ATRA EQ Biotechnology median
Gross margin 91.38% 100.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (58.98%) (56.66%)
Return on assets (57.62%) (50.68%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA EQ Biotechnology median
Revenue growth (TTM) (96.72%) 13.89% 5.64%
EPS growth (last fiscal year) 122.52% (69.57%) 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA EQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 23.40 4.72
Net debt to EBITDA (0.22) 1.29 0.96

Dividend

Metric ATRA EQ Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ATRA EQ Biotechnology median
Market cap 92.64m 91.31m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack